CONN’S Stock Rating Reaffirmed by Stifel Nicolaus (CONN)

Share on StockTwits

Stifel Nicolaus reiterated their buy rating on shares of CONN’S (NASDAQ: CONN) in a research report sent to investors on Tuesday morning, Stock Ratings Network.com reports. The firm currently has a $57.00 price target on the stock.

Shares of CONN’S (NASDAQ: CONN) opened at 48.46 on Tuesday. CONN’S has a 52 week low of $14.40 and a 52 week high of $44.91. The stock’s 50-day moving average is currently $38.29. The company has a market cap of $1.706 billion and a P/E ratio of 31.06.

CONN has been the subject of a number of other recent research reports. Analysts at SunTrust raised their price target on shares of CONN’S from $50.00 to $57.00 in a research note to investors on Tuesday. Separately, analysts at Canaccord Genuity raised their price target on shares of CONN’S from $53.00 to $63.00 in a research note to investors on Tuesday, May 21st. They now have a buy rating on the stock. Finally, analysts at Oppenheimer initiated coverage on shares of CONN’S in a research note to investors on Tuesday, April 23rd. They set an outperform rating and a $54.00 price target on the stock.

Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $48.57.

Conn’s, Inc. is a specialty retailer of consumer products, and also provides consumer finance for the purchase of the products that it offers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

Pentagon Teaming Up with Boeing and Apple for Wearable Tech
Pentagon Teaming Up with Boeing and Apple for Wearable Tech
One-Hour Delivery by Amazon Arrives in Seattle
One-Hour Delivery by Amazon Arrives in Seattle
Dangerous Bacteria in Ground Beef Shows Study
Dangerous Bacteria in Ground Beef Shows Study
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Sears Reports Profit for the Quarter But Sales Drop
Sears Reports Profit for the Quarter But Sales Drop
Lenovo Sets Up Manufacturing Facility in India
Lenovo Sets Up Manufacturing Facility in India


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.